Leaders behind the first COVID-19 vaccine to receive FDA emergency use authorization highlight the role of technology in the quick development of the candidate.
HHS and VA officials are looking to holistic, cloud-based capabilities to get more out of their data.
FDA's post-surveillance methods ensure the continued safety of a vaccine through the collection and monitoring of health data.
The last thing federal agencies, especially health agencies, should do is allow their cyber vigilance to slip.
FDA is modernizing its technology infrastructure to accelerate scientific and regulatory decisions.
The agency is updating its guidance around vaccine authorization and will require investments in technology for its distribution.